ID: ALA2315316

Max Phase: Preclinical

Molecular Formula: C7H11NS3

Molecular Weight: 205.37

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 2-(Sec-Butyldisulfanyl)Thiazole
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CCC(C)SSc1nccs1

    Standard InChI:  InChI=1S/C7H11NS3/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3

    Standard InChI Key:  NLEPKZJPFCAMTO-UHFFFAOYSA-N

    Associated Targets(Human)

    Thioredoxin 111 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 205.37Molecular Weight (Monoisotopic): 205.0054AlogP: 3.68#Rotatable Bonds: 4
    Polar Surface Area: 12.89Molecular Species: NEUTRALHBA: 4HBD: 0
    #RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
    CX Acidic pKa: CX Basic pKa: 1.15CX LogP: 3.55CX LogD: 3.55
    Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.70Np Likeness Score: -0.99

    References

    1. DiRaimondo TR, Plugis NM, Jin X, Khosla C..  (2013)  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.,  56  (3): [PMID:23327656] [10.1021/jm301775s]

    Source